Global Biliary Stents Market Research Report 2022
Biliary stents are small mesh-like tubes, which do not contain any coating or covering. Stents are inserted into the liver to treat hepatic blockage and obstructive hepatic diseases, such as jaundice, cholecystitis, hepato-biliary diseases, and cholangitis. Biliary stents are utilized to treat obstruction present in the bile duct.
Due to the COVID-19 pandemic, the global Biliary Stents market size is estimated to be worth US$ 210.6 million in 2021 and is forecast to a readjusted size of US$ 267.4 million by 2028 with a CAGR of 3.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biliary Stents market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biliary Stents landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Increase in demand for minimally invasive techniques, technological advancements, and rise in geriatric populations are key drivers for the growth of market. In addition, increase in awareness of the population and rise in demand for bioresorbable stents fuel the market growth. The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global biliary stents market until the end of 2021. The market is witnessing an increasing demand for MI procedures to treat biliary diseases because these procedures deliver superior results with minimal complications and are increasingly used to manage diseases such as gallbladder-related diseases, pancreas-related diseases, and liver-related diseases. The Americas accounted for the majority market share during 2016 and will continue to dominate the market throughout the forecast period owing to the increasing prevalence of gastrointestinal disorders.
This report focuses on Biliary Stents volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biliary Stents market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Biliary Stents Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Metal Stents
Plastic Stents
Segment by Application
Hospitals
ASC
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott Vascular
Boston Scientific
Cook Medical
C. R. Bard
Medtronic
Taewoong Medical
Due to the COVID-19 pandemic, the global Biliary Stents market size is estimated to be worth US$ 210.6 million in 2021 and is forecast to a readjusted size of US$ 267.4 million by 2028 with a CAGR of 3.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biliary Stents market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biliary Stents landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Increase in demand for minimally invasive techniques, technological advancements, and rise in geriatric populations are key drivers for the growth of market. In addition, increase in awareness of the population and rise in demand for bioresorbable stents fuel the market growth. The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global biliary stents market until the end of 2021. The market is witnessing an increasing demand for MI procedures to treat biliary diseases because these procedures deliver superior results with minimal complications and are increasingly used to manage diseases such as gallbladder-related diseases, pancreas-related diseases, and liver-related diseases. The Americas accounted for the majority market share during 2016 and will continue to dominate the market throughout the forecast period owing to the increasing prevalence of gastrointestinal disorders.
This report focuses on Biliary Stents volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biliary Stents market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Biliary Stents Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Metal Stents
Plastic Stents
Segment by Application
Hospitals
ASC
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott Vascular
Boston Scientific
Cook Medical
C. R. Bard
Medtronic
Taewoong Medical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
